
Vanicef-S 1.5 Injection
Marketer
Vanshita Lifecare
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Vanicef-S 1.5 Injection
Cefixime and Sulbactam injection (1.5g) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism targets microbial proliferation, halting infection spread. Administration must be solely under medical guidance. Consistent adherence to the prescribed schedule is crucial; completing the entire course is vital, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects, including nausea, vomiting, diarrhea, and dyspepsia, may occur. Severe reactions necessitate immediate medical attention. Allergic responses (skin rashes, pruritus, edema, respiratory distress) require prompt emergency care. Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness mandates abstention from driving. Adequate rest, a nutritious diet, and hydration promote faster recovery. Monitoring treatment efficacy may involve laboratory and diagnostic tests as determined by your doctor.
Uses of Vanicef-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Vanicef-S 1.5 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Vanicef-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Vanicef-S 1.5 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Vanicef-S 1.5 Injection works:
Ceftriaxone and sulbactam, combined as Vanicef-S 1.5 Injection, offer a potent antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Vanicef-S 1.5 Injection concurrent use with alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Vanicef-S 1.5 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Vanicef-S 1.5 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Vanicef-S 1.5 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Vanicef-S 1.5 Injection use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The administration of Vanicef-S 1.5 Injection requires careful consideration in individuals with advanced hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Vanicef-S 1.5 Injection dosage is generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Vanicef-S 1.5 Injection :
Omitting a scheduled dose of Vanicef-S 1.5 Injection warrants immediate physician consultation.
Facts to Know About Vanicef-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
